SARS-CoV-2 and dialysis: humoral response, clinical and laboratory impacts before vaccination

SARS-CoV-2 and dialysis: humoral response, clinical and laboratory impacts before vaccination

Background: Patients with kidney disease on Hemodialysis (HD) are susceptible to Coronavirus Disease (COVID-19) due to multiple risk factors. Aim: This study aims to report the prevalence of antibodies against SARS-CoV-2 among patients on hemodialysis before vaccination in Brazil and to compare with...

Full description

Bibliographic Details
Main Authors: Alanna Calheiros Santos, Vanessa Duarte da Costa, Lucas Lima da Silva, Juliana Custódio Miguel, Rodrigo Jardim, Alberto Martín Rivera Dávila, Vanessa Salete de Paula, Juliana Gil Melgaço, Barbara Vieira do Lago, Livia Melo Villar
Format: Article
Language:English
Published: Elsevier 2024-03-01
Series:Brazilian Journal of Infectious Diseases
Subjects:
SARS-CoV-2
Prevalence
Chronic kidney disease
Seroepidemiology
Covid-19 pandemic
Online Access:http://www.sciencedirect.com/science/article/pii/S1413867024000187

Internet

http://www.sciencedirect.com/science/article/pii/S1413867024000187

Similar Items